Metformin is associated with better survival rate of localized upper tract urothelial carcinoma patients with type 2 diabetes

Metformin is associated with better survival rate of localized upper tract urothelial carcinoma patients with type 2 diabetes

Purpose: Metformin, an antidiabetic drug, has been proposed to play a possible protective role in cancer recurrence and patient mortality. However, the exact mechanism and efficacy of metformin in urothelial cancer, especially upper tract urothelial carcinoma (UTUC), remain unknown. In this study, w...

Full description

Bibliographic Details
Main Authors: Chung-Yu Lin, Chien-Sheng Wang, Jhen-Hao Jhan, Hsiang-Ying Lee, Yi-Hsin Yang, Che-Wei Chang, Hung-Lung Ke, Ching-Chia Li, Yung-Chin Lee
Format: Article
Language:English
Published: Wolters Kluwer Health/LWW 2023-01-01
Series:Urological Science
Subjects:
diabetes
metformin
urothelial carcinoma
Online Access:http://www.e-urol-sci.com/article.asp?issn=1879-5226;year=2023;volume=34;issue=3;spage=155;epage=162;aulast=Lin

Internet

http://www.e-urol-sci.com/article.asp?issn=1879-5226;year=2023;volume=34;issue=3;spage=155;epage=162;aulast=Lin

Similar Items